Faculty profile

Pierre-Marie David

ResearcherHealth, Medical SociologyUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Pierre-Marie David

Researcher

Health, Medical Sociology

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 SSHRC), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

pharmaceutical policies health sociology equity exception access pharmaceuticalization médicament pharmaceuticalisation

Latest papers

Pharmaceutical Sovereignty as HIV Justice: Colombia's Dolutegravir License and the Future of ART Access in Latin America.
Journal of the International AIDS Society · 2026 · senior author
Evaluation of patients' perception of pharmacist's role within a post-ICU recovery clinic: the Critical Illness Recovery Center (E-PICS-Rx).
The International journal of pharmacy practice · 2026
Experiences and attitudes towards agitated behaviours in TBI ICU patients (EXSTATIC): understanding various management practices through qualitative interviews with nurses.
Brain injury · 2025

All 17 publications

Latest funding

Understanding Drug Exceptional Access Programs (DEAPs) Across Canada: A Question of Equity
SSHRC · 2023 · Principal investigator
$25,032
Understanding Drug Exceptional Access Programs (DEAPs) Across Canada: A Question of Equity
SSHRC · 2023 · Principal investigator
$97,898
Ethique et politique de l'«exception pharmaceutique»
SSHRC · 2021 · Principal investigator
$60,731

All 3 grants and awards

17 publications.

Pharmaceutical Sovereignty as HIV Justice: Colombia's Dolutegravir License and the Future of ART Access in Latin America.

Cifuentes LM, Brisson JB, Zea A, David PM

Journal of the International AIDS Society2026Senior author

DOI: 10.1002/jia2.70137 PMID: 42502252

Evaluation of patients' perception of pharmacist's role within a post-ICU recovery clinic: the Critical Illness Recovery Center (E-PICS-Rx).

Le A, Xu CQ, Noé B, Khatem M, Rainone A, David PM, Hornstein D, Wright J, Mailman J, Perreault M, Moussa G

The International journal of pharmacy practice2026

DOI: 10.1093/ijpp/riag066 PMID: 42160206

Experiences and attitudes towards agitated behaviours in TBI ICU patients (EXSTATIC): understanding various management practices through qualitative interviews with nurses.

Saavedra-Mitjans M, David PM, Arbour C, Perreault MM, Roux M, Frenette AJ, Khwaja K, Bernard F, Williamson DR

Brain injury2025

DOI: 10.1080/02699052.2025.2460022 PMID: 39895622

Understanding drug exceptional access programs (DEAPs) in Canada, and their associated social and political issues.

David PM, Lata KL, Bouthillier ME, Bélisle-Pipon JC

BMC medical ethics2024First author

DOI: 10.1186/s12910-024-01038-8 PMID: 38532443

Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review.

Chadi A, Thirion DJG, David PM

BMC public health2023Senior author

DOI: 10.1186/s12889-023-16601-y PMID: 37741997

Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.

Dagenais C, Kielende M, Coulibaly A, Gautier L, David PM, Peiffer-Smadja N, Honda A, de Araújo Oliveira SR, Traverson L, Zinszer K, Ridde V

Health systems and reform2023

DOI: 10.1080/23288604.2023.2231644 PMID: 37470503

Artificial intelligence-based computer aided detection (AI-CAD) in the fight against tuberculosis: Effects of moving health technologies in global health.

Onno J, Ahmad Khan F, Daftary A, David PM

Social science & medicine (1982)2023Senior author

DOI: 10.1016/j.socscimed.2023.115949 PMID: 37207379

Structuring and organizing interprofessional healthcare in partnership with patients with diabetes: the INterprofessional Management and Education in Diabetes care (INMED) pathway.

Layani G, Vachon B, Duhoux A, Lussier MT, Gil J, Brault I, Vanier MC, Rodrigues I, Motulsky A, Kaczorowski J, David PM, Battaglini A

Journal of interprofessional care2023

DOI: 10.1080/13561820.2022.2051452 PMID: 35403546

Conditions required for the artificial-intelligence-based computer-aided detection of tuberculosis to attain its global health potential.

David PM, Onno J, Keshavjee S, Ahmad Khan F

The Lancet. Digital health2022First author

DOI: 10.1016/s2589-7500(22)00172-8 PMID: 36150780

Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy.

Tavaziva G, Harris M, Abidi SK, Geric C, Breuninger M, Dheda K, Esmail A, Muyoyeta M, Reither K, Majidulla A, Khan AJ, Campbell JR, David PM, Denkinger C, Miller C, Nathavitharana R, Pai M, Benedetti A, Ahmad Khan F

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

DOI: 10.1093/cid/ciab639 PMID: 34286831

Something wrong or missing on this profile? Suggest a correction

Pierre-Marie David

Research

Latest papers

Latest funding

Pharmaceutical Sovereignty as HIV Justice: Colombia's Dolutegravir License and the Future of ART Access in Latin America.

Evaluation of patients' perception of pharmacist's role within a post-ICU recovery clinic: the Critical Illness Recovery Center (E-PICS-Rx).

Experiences and attitudes towards agitated behaviours in TBI ICU patients (EXSTATIC): understanding various management practices through qualitative interviews with nurses.

Understanding drug exceptional access programs (DEAPs) in Canada, and their associated social and political issues.

Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review.

Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.

Artificial intelligence-based computer aided detection (AI-CAD) in the fight against tuberculosis: Effects of moving health technologies in global health.

Structuring and organizing interprofessional healthcare in partnership with patients with diabetes: the INterprofessional Management and Education in Diabetes care (INMED) pathway.

Conditions required for the artificial-intelligence-based computer-aided detection of tuberculosis to attain its global health potential.

Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy.

Understanding Drug Exceptional Access Programs (DEAPs) Across Canada: A Question of Equity

Understanding Drug Exceptional Access Programs (DEAPs) Across Canada: A Question of Equity

Ethique et politique de l'«exception pharmaceutique»

Frequent collaborators

Faiz Ahmad Khan

Caroline Arbour

Francis Bernard

Andrea Benedetti

Aude Motulsky

David Williamson

Marie-Eve Bouthillier

Isabel Rodrigues

Madhukar Pai

Brigitte Vachon

Janusz Kaczorowski

Amrita Daftary